Role for oxidative stress in the regeneration of islet beta cells?

Kathryn Haskins1, Jennifer Kench, Katherine Powers

  • 1Department of Immunology, University of Colorado Health Sciences Center, 1400 Jackson Street, Denver, CO 80206, USA. katie.haskins@uchsc.edu

Insights

Oxidative stress in pancreatic islet beta cells is increased in prediabetic nonobese diabetic (NOD) mice. Treating these mice with a superoxide dismutase (SOD) mimetic reduced oxidative stress markers, suggesting a potential therapeutic target for type 1 diabetes.

Area of Science:

  • Immunology
  • Endocrinology
  • Cell Biology

Background:

  • Nonobese diabetic (NOD) mice are a model for type 1 diabetes.
  • Prediabetic NOD mice exhibit increased oxidative stress in pancreatic islet beta cells.
  • Oxidative stress contributes to beta cell dysfunction and loss in type 1 diabetes.

Purpose of the Study:

  • To investigate the role of oxidative stress in the pathogenesis of type 1 diabetes in NOD mice.
  • To explore the potential of superoxide dismutase (SOD) mimetics as a therapeutic strategy.
  • To examine the relationship between beta cell regeneration and oxidative stress resistance.

Main Methods:

  • Assessment of oxidative stress markers (nitrotyrosine) in islets of prediabetic NOD mice and control strains.
  • Treatment of prediabetic NOD mice with a SOD mimetic.
  • Analysis of beta cell proliferation and apoptosis in islets of NOD mice and a diabetes-resistant NOD congenic strain (NOD.Lc7).

Main Results:

  • Prediabetic NOD mice showed increased oxidative stress markers in islet beta cells compared to controls.
  • SOD mimetic treatment significantly reduced nitrotyrosine levels in NOD mouse islets.
  • NOD.Lc7 mice exhibited increased beta cell proliferation, decreased apoptosis, and lower nitrotyrosine levels, indicating greater oxidative stress resistance.

Conclusions:

  • Oxidative stress is a significant factor in the development of type 1 diabetes in NOD mice.
  • SOD mimetics show promise in mitigating oxidative damage to pancreatic islets.
  • A potential link exists between enhanced beta cell regeneration and resistance to oxidative stress in type 1 diabetes pathogenesis.

Related Concept Videos

Tissue Renewal without Stem Cells01:23

Tissue Renewal without Stem Cells

After cellular or tissue damage, the resident stem cells present in the human body can locally repair and regenerate the damaged tissue or organ. However, even though some tissues do not have stem cells, they can repair and regenerate with the help of pre-existing cells. For example, beta cells of the pancreas and hepatocytes of the liver can divide to renew and regenerate the tissue. Here, both cell division and cell death are well regulated by homeostasis.
However, failure of such a system...
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion01:27

Glucose Homeostasis: Pancreatic Islets and Insulin Secretion

The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are co-secreted in...
Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Hormones Regulating Blood Glucose01:16

Hormones Regulating Blood Glucose

Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...